Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Adjuvant Treatment in Metastatic Breast Cancer
NCT04143282Phase 2Completed
- Start
- Oct 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in breast cancer. Started Oct 2019; status: completed.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04143282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04143282.